Skip to content

BAT

DRUG14 trials

Sponsors

Chang Gung Memorial Hospital, Emergent BioSolutions, Helsinki University Central Hospital, RWTH Aachen University, GlaxoSmithKline

Conditions

ARDS, HumanAcute Graft-versus-host DiseaseAcute PyelonephritisBotulismCOVID19Cerebrovascular AccidentComplicated Intra-abdominal InfectionComplicated Urinary Tract Infection

Phase 1

Phase 2

The Ruxo-BEAT Trial in Patients With High-risk Polycythemia Vera or High-risk Essential Thrombocythemia
Active, not recruitingNCT02577926
RWTH Aachen UniversityEssential Thrombocythemia (ET), Polycythemia Vera (PV)
Start: 2015-10-31End: 2028-12-31Updated: 2025-06-10
Prevention and Treatment With Calcifediol of COVID-19 Induced Acute Respiratory Syndrome
CompletedNCT04366908
Maimónides Biomedical Research Institute of CórdobaCOVID19, Cytokine Release Syndrome, Cytokine Storm +2
Start: 2020-05-07End: 2022-04-19Updated: 2023-03-03
Pilot Study of Single Dose Bevacizumab as Treatment for Acute Respiratory Distress Syndrome (ARDS) in COVID-19 Patients
TerminatedNCT04954014
Maimónides Biomedical Research Institute of CórdobaARDS, Human, Coronavirus Infection
Start: 2020-09-01End: 2021-08-31Updated: 2021-09-05
Study of 2 Medicines (Aztreonam and Avibactam) Compared to Best Available Therapy for Serious Gram-negative Infections
RecruitingNCT05639647
PfizerGram-negative Bacterial Infections
Start: 2023-04-18End: 2026-08-17Target: 48Updated: 2026-03-25
PK of BV100 in Patients VABP Suspected or Confirmed to Be Due to CRAB
CompletedNCT05685615
BioVersys AGVentilator Associated Pneumonia
Start: 2023-04-20End: 2024-12-11Updated: 2025-01-14
Trial of Efficacy and Safety of MC0518 Versus Best Available Therapy in Participants With Steroid-Refractory Acute Graft Versus Host Disease
Active, not recruitingNCT06075706
medac GmbHSteroid-refractory Acute Graft-versus-host Disease
Start: 2023-11-13End: 2031-06-01Target: 48Updated: 2026-01-27

Phase 3

Unknown Phase

Related Papers